Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-005175)

Filing Details

Accession Number:: 0001181431-13-005175
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-01-28 17:51:26
Reporting Period:: 2013-01-24

Filing Date:: 2013-01-28
Accepted Time:: 2013-01-28 17:51:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1325879	Aveo Pharmaceuticals Inc	AVEO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1486428	William Slichenmyer	C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-01-24	37,500	$0.00	61,193	No	4	A	Direct
Common Stock	Disposition	2013-01-28	1,150	$7.77	60,043	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right-to-buy)	Acquisiton	2013-01-24	32,500	$0.00	32,500	$7.72

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
32,500		2023-01-24	No	4	A	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2011, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
This option vests in equal monthly installments from January 1, 2013 through January 1, 2017.